ARTICLE

FindCenter AddIcon

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

By Tanya Lewis — 2020

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

Read on www.scientificamerican.com

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

A Dose of a Hallucinogen from a ‘Magic Mushroom,’ and then Lasting Peace

Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Article
Jan Hoffman
2016
FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

Article
Sophie Putka
2021
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research